Genetics is one of the most exciting fields in relation to modern health advances. The Merriam Webster Dictionary definition of genetics is “1: a branch of biology that deals with the heredity and variation of organs and 2: the genetic makeup and phenomena of an organism, type, group or condition”.
A late 19th-century scientist, named Gregor Mendel discovered and is responsible for the development of genetic identification process and named it ‘trait inheritance patterns’. This was done by studying pea plants and observing inherited characteristics. Common terms used in genetic studies are ‘genes’ and ‘DNA’. The term ‘genetics’ was first used by Imre Festetics, a Hungarian nobleman.
Genetic studies and experiments have led to a large number of advances in the medical arena regarding various diseases. One of the companies well known in this field is Seattle Genetics, which was founded in 1998 and is currently working on “…antibody-drug conjugates for the treatment of cancer”. Basically, this involves directing antibody-drug conjugates (ABCs) to attack cancer cells.
Dr. Clay Siegall is the company’s current CEO and chairman of the board working since its inception in 1998. Under his guidance, the company has produced over $675 million with its capital raising activities in the biotechnology field. Its current headquarters are located in Bothell, Washington. Currently the company is working on two pipeline programs, SGN-CD33A and SGN-CD19A, which will be combined with R-ICE chemotherapy for cancer treatment.
Dr. Siegall has an interesting history. He has held the company’s CEO position for the past 18 years and has extensive training both in education and in his former employment. Prior to Seattle Genetics, he worked with such firms as Bristol-Myers Squibb Pharmaceutical Research Institute, the National Institute of Health and the National Cancer Institute. He is currently serving as director of a number of private companies.
Seattle Genetics is proud of its team who shares ideas and skills with a passion for helping patients who have cancer. As a result, they exhibit honesty, respect and trust while using all means available to obtain a breakthrough in eliminating this dreadful disease.